Three-Statement Breakdown
REVENUE UP
Revenue rose 18% year over year to $4.5B, and carried a 7.6% net margin.
REVENUE
+17.6%
4,480
GROSS PROFIT
—
—
NET INCOME
-55.3%
340
EPS (DILUTED)
-58.0%
$0.37
| Income statement | 24-09 | 24-12 | 25-03 | 25-06 | 25-09 | 25-12 | 26-03 | QoQ | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,941 | 3,400 | 4,076 | 3,810 | 4,527 | 4,093 | 5,019 | 4,480 | -10.7% | +17.6% | |
| Operating income | 1,218 | 391 | 1,223 | 1,096 | 1,339 | 756 | 1,392 | 329 | -76.4% | -70.0% | |
| Interest expense |
RESTATED · WAS (480)
10-Q
|
(404) | (445) | (481) | (505) | (527) | (509) | (561) | (555) | -1.1% | +9.9% |
| Income tax |
RESTATED · WAS (55)
10-Q
|
(213) | (31) | (40) | (220) | (216) | (56) | (48) | (122) | +154.2% | -44.5% |
| Net income |
RESTATED · WAS 646
10-Q
|
934 | 134 | 665 | 760 | 1,006 | 567 | 621 | 340 | -45.2% | -55.3% |
| EPS (diluted) |
RESTATED · WAS $0.75
10-Q
|
$1.09 | $0.14 | $0.77 | $0.88 | $1.16 | $0.65 | $0.69 | $0.37 | -46.4% | -58.0% |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-31 ↗